ARTICLE | Clinical News
FDA approves label expansion for AMAG's Feraheme
February 9, 2018 4:19 PM UTC
FDA approved an sNDA from AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) to expand the label of Feraheme ferumoxytol to treat iron deficiency anemia (IDA) in adults with intolerance or insufficient response to oral iron...
BCIQ Company Profiles